| Steven Paul Schinkal Jr, PA-C | |
|
7831 Chicago Ct, Omaha, NE 68114-3654 | |
| (402) 354-1230 | |
| (402) 354-5621 |
| Full Name | Steven Paul Schinkal Jr |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 7831 Chicago Ct, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376063214 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 2996 (Nebraska) | Secondary |
| 363AM0700X | Physician Assistant - Medical | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
| Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
| Aurora Medical Center - Summit | Summit, WI | Hospital |
| West Allis Memorial Hospital | West allis, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Infectious Disease Specialists Of Se Wi, Sc | 5890697874 | 15 |
News Archive
PBS NewsHour examines how the Canadian organization MEDA is using text messages to track malaria supplies in local clinics and retailers in Tanzania. The piece includes a related video featuring a MEDA employee giving a tour of the program (Cheers, 7/22).
Acorda Therapeutics, Inc. today announced that it has acquired two neuropathic pain management assets from NeurogesX, Inc. Qutenza is approved by the U.S. Food and Drug Administration for the management of neuropathic pain associated with postherpetic neuralgia.
In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.
Abt Associates will conduct a study for the Centers for Disease Control and Prevention (CDC) to evaluate the effectiveness of the H1N1 and seasonal flu vaccines among pregnant women, one of the high risk populations identified by CDC.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has received notice from the U.S. Food & Drug Administration confirming an Orphan Drug Designation of BL-8040 as a treatment for stem cell mobilization, in addition to the Orphan Drug Designation previously granted to BL-8040 as a treatment for Acute Myeloid Leukemia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven Paul Schinkal Jr, PA-C Po Box 3755, Omaha, NE 68103-0755 Ph: (402) 354-1230 | Steven Paul Schinkal Jr, PA-C 7831 Chicago Ct, Omaha, NE 68114-3654 Ph: (402) 354-1230 |
News Archive
PBS NewsHour examines how the Canadian organization MEDA is using text messages to track malaria supplies in local clinics and retailers in Tanzania. The piece includes a related video featuring a MEDA employee giving a tour of the program (Cheers, 7/22).
Acorda Therapeutics, Inc. today announced that it has acquired two neuropathic pain management assets from NeurogesX, Inc. Qutenza is approved by the U.S. Food and Drug Administration for the management of neuropathic pain associated with postherpetic neuralgia.
In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.
Abt Associates will conduct a study for the Centers for Disease Control and Prevention (CDC) to evaluate the effectiveness of the H1N1 and seasonal flu vaccines among pregnant women, one of the high risk populations identified by CDC.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has received notice from the U.S. Food & Drug Administration confirming an Orphan Drug Designation of BL-8040 as a treatment for stem cell mobilization, in addition to the Orphan Drug Designation previously granted to BL-8040 as a treatment for Acute Myeloid Leukemia.
› Verified 4 days ago
Neil C Jouvenat Ii, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4242 Farnam St Ste 650, Omaha, NE 68131 Phone: 402-559-8600 | |
Jennifer M Vaughn, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 601 N 30th St, Omaha, NE 68131 Phone: 402-449-4590 | |
Karen R Schrader, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-8715 | |
Bridget A Burke, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-8000 Fax: 402-559-8746 | |
Ms. Robbie L Lane, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 8111 Dodge St, Suite 237, Omaha, NE 68114 Phone: 402-354-5210 | |
Mr. Ray Everett Skelton, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 987400 Nebraska Medical Center, Omaha, NE 68198 Phone: 402-559-7592 | |
Kimberly Mccolley, P.A.-C. Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-8715 |